Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia
Leukemia · 2024-11 · 38 (11) · 2366-2375
DOI: 10.1038/s41375-024-02403-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia, online erschienen am 04.09.2024. Verfasst von Cédric G van der Ham und 11 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Mutation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: KWF Kankerbestrijding (Dutch Cancer Society).
Abstract (Originalsprache)
Pediatric acute lymphoblastic leukemia (ALL) is marked by low mutational load at initial diagnosis, which increases at relapse. To determine which processes are active in (relapsed) ALL and how they behave during disease progression before and after therapy, we performed whole genome sequencing on 97 tumor samples of 29 multiply relapsed ALL patients. Mutational load increased upon relapse in 28 patients and upon every subsequent relapse in 22 patients. In addition to two clock-like mutational processes, we identified UV-like damage, APOBEC activity, reactive oxygen species, thiopurine-associated damage and an unknown therapy component as drivers of mutagenesis. Mutational processes often affected patients over longer time periods, but could also occur in isolated events, suggesting the requirement of additional triggers. Thiopurine exposure was the most prominent source of new mutations in relapse, affecting over half of the studied patients in first and/or later relapse and causing potential relapse-driving mutations in multiple patients. Our data demonstrate that multiple mutational processes frequently act in parallel as prominent secondary drivers with dynamic activity during ALL development and progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
- Dutch Childhood Oncology Group, Utrecht, The Netherlands.
- Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. r.kuiper@prinsesmaximacentrum.nl.
- Department of Genetics, Utrecht University Medical Center, Utrecht University, Utrecht, The Netherlands. r.kuiper@prinsesmaximacentrum.nl.
ORCID-Profile: Cédric G van der Ham, Lianne C Suurenbroek, Željko Antić, Vincent H J van der Velden, Frank N van Leeuwen, Roland P Kuiper
Förderung
- KWF Kankerbestrijding (Dutch Cancer Society)
Zitieren
APA
van der Ham, C. G., Suurenbroek, L. C., Kleisman, M. M., Antić, Ž., Lelieveld, S. H., Yeong, M., Westera, L., Sonneveld, E., Hoogerbrugge, P. M., van der Velden, V. H. J., van Leeuwen, F. N., & Kuiper, R. P. (2024). Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia. Leukemia, 38(11), 2366-2375. https://doi.org/10.1038/s41375-024-02403-7
Vancouver
van der Ham CG, Suurenbroek LC, Kleisman MM, Antić Ž, Lelieveld SH, Yeong M, et al. Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia. Leukemia. 2024;38(11):2366-2375. doi:10.1038/s41375-024-02403-7
BibTeX
@article{vanderHam2024,
author = {van der Ham, Cédric G and Suurenbroek, Lianne C and Kleisman, Michelle M and Antić, Željko and Lelieveld, Stefan H and Yeong, Marley and Westera, Liset and Sonneveld, Edwin and Hoogerbrugge, Peter M and van der Velden, Vincent H J and van Leeuwen, Frank N and Kuiper, Roland P},
title = {Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia},
journal = {Leukemia},
year = {2024},
volume = {38},
number = {11},
pages = {2366--2375},
doi = {10.1038/s41375-024-02403-7}
}
EUVIMED